Sign up for our FREE Weekly Newsletter
Current Issue
Past Issue
News and Information for Medical Professionals
Search Diabetes In Control
 
 
Bookmark and Share | Print | Category | Home Previous | Next
This article originally posted 01 August, 2009 and appeared in  Issue 480
Medingo Introduces Solo™ MicroPump Insulin Delivery System

Medingo US, Inc., announced that it will introduce its miniature, tube-free insulin delivery system, the Solo MicroPump, at the American Association of Diabetes Educators Meeting in Atlanta, GA, August 5-8, 2009, Booth 730 . The company received its FDA clearance letter (K090245) on July 28, 2009.

The Solo MicroPump will be the smallest, lightest, most discreet full-featured insulin pump on the market. In addition, it will offer highly desired pump features, such as detachability and the ability to bolus directly on the MicroPump.

 
"We are extremely pleased to have achieved this major milestone for Medingo," commented Ofer Yodfat, MD, founder of Medingo. 
 
"We designed Solo with input from hundreds of insulin-requiring people with diabetes and their caregivers. As a result, we believe Solo offers people with diabetes significantly greater freedom and flexibility in the management of their condition. In addition, our 'pay-as-you-pump' pricing model will allow easier access to Solo through a very low upfront cost."
 
Medingo develops products specifically for the needs of people with diabetes. The Medingo technology may serve as a platform for other medications.
 
Medingo's Israeli headquarters are located in Yoqneam, and its U.S. headquarters are located in Tampa, FL.
 
For more information, please visit www.solo4you.com.
 
 

Bookmark and Share | Print | Category | Home

This article originally posted 01 August, 2009 and appeared in  Issue 480

Past five issues: Issue 495 | Issue 494 | Issue 493 | Issue 492 | Issue 491 |

Recent Most Read Articles:

Obesity Reduces Survival By 2 Years
Posted March 31, 2009
 Not Enough Sleep Causes More Eating and Diabetes Risk
Posted May 01, 2009
 Test Your Knowledge Issue 469
Posted May 19, 2009
 Generex Biotechnology Announces Successful Phase III Study Data for Generex Oral-lyn(tm)
Posted March 17, 2009
 Test Your Knowledge Issue 457
Posted February 24, 2009
 Discovery of a New Receptor Antagonist Predicts Diabetes 2 Onset
Posted April 18, 2009
 Letter From The Editor. June 29, 2009 Issue #475
Posted June 29, 2009
 Artificial Sweeteners Linked to Two-Fold Increase in Diabetes
Posted June 23, 2009
 Lantus Insulin: A Possible Link with Cancer - Requires Further Investigation
Posted June 29, 2009
 New Buccal Insulin Approved by the FDA but with Conditions
Posted September 12, 2009
See more most read...


Enhancing physiology; Mechanism targets 2 key defects: insulin release and hepatic glucose production. Click here to learn more.




Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead | Did You Know | Education | Facts | Feature | Items for the Week | New Products | Newsflash | Press Releases | Studies | Test Your Knowledge | Test Your Knowledge Answers | Tools |

Diabetes In Control Advertisers

Print This Week's Newsletter
Download This Week's Newsletter
Newsletter is in Adobe format
If you don't haveAdobe Acrobat Reader , you can download it for Free here .

Free CE Available
CE Programs On Diabetes Available here

Search Articles On Diabetes In Control
Sign up for our FREE Weekly Newsletter
Current Issue
Past Issue
Privacy / Advertising With Us / Contact Us
Add us to your favorite news reader
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.